November 10, 2014

Health Mart on Monday announced that it is hosting its second series of Town Hall meetings, “Pharmacy Quality Measures: Action Steps for Improvement.”

July 10, 2014

The Office of National Drug Control Policy released the 2014 National Drug Control Strategy, the Obama Administration’s primary blueprint for drug policy in the United States.

November 22, 2013

Canadian pharmacy retailer Shoppers Drug Mart has announced that the Supreme Court of Canada has upheld the Dec. 23, 2011, decision of the Court of Appeal of Ontario that restored the prohibition on private-label generic drug products in the Province of Ontario, which was subsequent to a decision of the Ontario Divisional Court dated Feb. 3, 2011, that declared the regulatory restrictions in respect of private-label generic drug products to be invalid.

September 5, 2013

Building on its government affairs and public policy department, the National Association of Chain Drug Stores has hired Christopher Smith, formerly with the National Community Pharmacists Association, as director of federal public policy.

June 24, 2013

The National Association of Chain Drug Stores has promoted Kevin Nicholson to the new position of VP public policy and regulatory affairs, effective Monday.

May 20, 2013

A recent survey commissioned on behalf of a pharmacy benefit manager trade group found a high degree of satisfaction among Medicare Part D beneficiaries with preferred pharmacy plans.

January 31, 2012

For every dollar spent on over-the-counter medicines, the U.S. healthcare system realizes a savings of between $6 and $7, or $102 billion all told, the Consumer Healthcare Products Association announced Tuesday with the release of this new study, "The Value of OTC Medicine to the United States."

September 1, 2011

Branded drugs sold under their generic names at a reduced price can reduce retail and wholesale drug prices, according to a new report by the Federal Trade Commission.

January 31, 2010

With the defeat of Democrat Martha Coakley by Republican Scott Brown in the race to fill the seat of late Massachusetts Sen. Ted Kennedy, and the loss of the Democrats’ filibuster-proof majority in the Senate, the healthcare-reform bill stands on a knife’s edge. And how will pharmacies be reimbursed for dispensing generic drugs to Medicaid and Medicare patients if a health overhaul bill fails to pass? These topics, along with the issue of patent settlements vexing the branded and generic drug industries and a new GAO study showing that drug costs are soaring, are explored in depth in the latest installment of the ECRM Generics report.